NCT01760525
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01760525 |
| Title | A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors |
| Acronym | CCGM097X2101 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | FRA | DEU | CHE |
CKB BOOST